99 related articles for article (PubMed ID: 17693934)
21. Galectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages.
Kadowaki T; Morishita A; Niki T; Hara J; Sato M; Tani J; Miyoshi H; Yoneyama H; Masaki T; Hattori T; Matsukawa A; Hirashima M
Crit Care; 2013 Dec; 17(6):R284. PubMed ID: 24321251
[TBL] [Abstract][Full Text] [Related]
22. Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands.
Hegde S; Lockridge JL; Becker YA; Ma S; Kenney SC; Gumperz JE
J Autoimmun; 2011 Aug; 37(1):28-38. PubMed ID: 21486688
[TBL] [Abstract][Full Text] [Related]
23. Neutrophils and natural killer T cells as negative regulators of wound healing.
Brubaker AL; Schneider DF; Kovacs EJ
Expert Rev Dermatol; 2011 Feb; 6(1):5-8. PubMed ID: 21442028
[No Abstract] [Full Text] [Related]
24. Prevention of NKT cell activation accelerates cutaneous wound closure and alters local inflammatory signals.
Schneider DF; Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Faunce DE
J Surg Res; 2011 Nov; 171(1):361-73. PubMed ID: 21067780
[TBL] [Abstract][Full Text] [Related]
25. Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.
Hegde S; Fox L; Wang X; Gumperz JE
Immunology; 2010 Aug; 130(4):471-83. PubMed ID: 20465577
[TBL] [Abstract][Full Text] [Related]
26. The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock.
Hu CK; Venet F; Heffernan DS; Wang YL; Horner B; Huang X; Chung CS; Gregory SH; Ayala A
J Immunol; 2009 Feb; 182(4):2467-75. PubMed ID: 19201902
[TBL] [Abstract][Full Text] [Related]
27. Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.
Pilones KA; Kawashima N; Yang AM; Babb JS; Formenti SC; Demaria S
Clin Cancer Res; 2009 Jan; 15(2):597-606. PubMed ID: 19147765
[TBL] [Abstract][Full Text] [Related]
28. CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.
Mi QS; Meagher C; Delovitch TL
Novartis Found Symp; 2003; 252():146-60; discussion 160-4, 203-10. PubMed ID: 14609217
[TBL] [Abstract][Full Text] [Related]
29. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
30. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
31. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
32. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
[TBL] [Abstract][Full Text] [Related]
33. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
34. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
